Literature DB >> 6238105

Characteristics of autoantibodies to human interferon in a patient with varicella-zoster disease.

B Pozzetto, K E Mogensen, M G Tovey, I Gresser.   

Abstract

A patient with varicella-zoster disease was found to have antibodies to human interferon. These antibodies included all IgG subclasses, showed a high combined affinity (average dissociation constant, 10(-11)M), and were present in serum at a concentration of 10(-9)M. The antibodies neutralized the activity of a series of human alpha-interferons prepared from recombinant DNA as well as that of naturally occurring mixtures of alpha-type interferon prepared by viral stimulation of human cells. Examination of the patient's lymphoid cells revealed normal production of interferon and normal expression of interferon receptors. Interferon from the patient's cells was neutralized by her serum. The neutralizing capacity of this serum was analyzed with regard to levels of interferon previously detected in patients with varicella-zoster infections.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6238105     DOI: 10.1093/infdis/150.5.707

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

1.  Neutralizing antibodies to granulocyte-macrophage colony-stimulating factor, interleukin-1alpha and interferon-alpha but not other cytokines in human immunoglobulin preparations.

Authors:  M Wadhwa; A Meager; P Dilger; C Bird; C Dolman; R G Das; R Thorpe
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

2.  Rogue antibodies could be driving severe COVID-19.

Authors:  Roxanne Khamsi
Journal:  Nature       Date:  2021-02       Impact factor: 49.962

3.  Levels of gamma interferon and interleukin-4 are inversely related to the levels of their corresponding autoantibodies in patients with lower respiratory tract infection.

Authors:  R ElKarim; C Granert; L Lindquist; H Link; M Bakhiet
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

Review 4.  Human genetic and immunological determinants of critical COVID-19 pneumonia.

Authors:  Qian Zhang; Paul Bastard; Aurélie Cobat; Jean-Laurent Casanova
Journal:  Nature       Date:  2022-01-28       Impact factor: 69.504

Review 5.  Mechanisms of viral inflammation and disease in humans.

Authors:  Jean-Laurent Casanova; Laurent Abel
Journal:  Science       Date:  2021-11-25       Impact factor: 63.714

6.  Induction of cytokines and anti-cytokine autoantibodies in cerebrospinal fluid (CSF) during experimental bacterial meningitis.

Authors:  M Bakhiet; M Mustafa; J Zhu; R Harris; L Lindquist; H Link; A Diab
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

7.  Naturally occurring anti-interferon-alpha 2a antibodies in patients with acute viral hepatitis.

Authors:  Y Ikeda; G Toda; N Hashimoto; N Umeda; K Miyake; M Yamanaka; K Kurokowa
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

8.  Spontaneous interferon-alpha antibodies in a patient with pure red cell aplasia and recurrent cutaneous carcinomas.

Authors:  O Prümmer; N Frickhofen; W Digel; H Heimpel; F Porzsolt
Journal:  Ann Hematol       Date:  1991 Feb-Mar       Impact factor: 3.673

9.  High avidity IFN-neutralizing antibodies in pharmaceutically prepared human IgG.

Authors:  C Ross; M Svenson; M B Hansen; G L Vejlsgaard; K Bendtzen
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

10.  Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency.

Authors:  Jolan E Walter; Lindsey B Rosen; Krisztian Csomos; Jacob M Rosenberg; Divij Mathew; Marton Keszei; Boglarka Ujhazi; Karin Chen; Yu Nee Lee; Irit Tirosh; Kerry Dobbs; Waleed Al-Herz; Morton J Cowan; Jennifer Puck; Jack J Bleesing; Michael S Grimley; Harry Malech; Suk See De Ravin; Andrew R Gennery; Roshini S Abraham; Avni Y Joshi; Thomas G Boyce; Manish J Butte; Kari C Nadeau; Imelda Balboni; Kathleen E Sullivan; Javeed Akhter; Mehdi Adeli; Reem A El-Feky; Dalia H El-Ghoneimy; Ghassan Dbaibo; Rima Wakim; Chiara Azzari; Paolo Palma; Caterina Cancrini; Kelly Capuder; Antonio Condino-Neto; Beatriz T Costa-Carvalho; Joao Bosco Oliveira; Chaim Roifman; David Buchbinder; Attila Kumanovics; Jose Luis Franco; Tim Niehues; Catharina Schuetz; Taco Kuijpers; Christina Yee; Janet Chou; Michel J Masaad; Raif Geha; Gulbu Uzel; Rebecca Gelman; Steven M Holland; Mike Recher; Paul J Utz; Sarah K Browne; Luigi D Notarangelo
Journal:  J Clin Invest       Date:  2015-10-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.